🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Novozymes AS (NVZMY)

OTC Markets
Currency in USD
58.55
+0.07(+0.12%)
Delayed Data
NVZMY Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Fair Value
Day's Range
58.5059.09
52 wk Range
49.9972.50
Key Statistics
Edit
Prev. Close
58.48
Open
59.08
Day's Range
58.5-59.09
52 wk Range
49.99-72.5
Volume
8.34K
Average Volume (3m)
11.87K
1-Year Change
12.95%
Book Value / Share
25.37
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NVZMY Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
75.50
Upside
+28.95%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

Novozymes AS Company Profile

Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novonesis A/S was founded in 1925 and is based in Bagsvaerd, Denmark.

Industry
Chemicals
Employees
10452

Compare NVZMY to Peers and Sector

Metrics to compare
NVZMY
Peers
Sector
Relationship
P/E Ratio
91.3x17.9x−0.1x
PEG Ratio
−2.390.020.00
Price/Book
2.3x1.7x1.6x
Price / LTM Sales
8.5x1.3x1.3x
Upside (Analyst Target)
29.1%16.9%27.3%
Fair Value Upside
Unlock11.9%1.6%Unlock

Analysts' Recommendations

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 75.50

(+28.95% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.02
Dividend Yield
1.26%
Industry Median 1.57%
Annualized payout
0.7339
Paid semi-annually
5-Years Growth
-
Growth Streak

People Also Watch

8.46
AMKBY
0.02%
33.57
CGEMY
-0.10%
12.05
RBGLY
-0.70%
91.58
PCVX
-0.52%

FAQ

What Is the Novozymes AS (NVZMY) Stock Price Today?

The Novozymes AS stock price today is 58.55

What Stock Exchange Does Novozymes AS Trade On?

Novozymes AS is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Novozymes AS?

The stock symbol for Novozymes AS is "NVZMY."

Does Novozymes AS Pay Dividends? What’s The Current Dividend Yield?

The Novozymes AS dividend yield is 1.26%.

What Is the Novozymes AS Market Cap?

As of today, Novozymes AS market cap is 27.37B.

What is Novozymes AS Earnings Per Share?

The Novozymes AS EPS is 1.02.

What Is the Next Novozymes AS Earnings Date?

Novozymes AS will release its next earnings report on Feb 25, 2025.

From a Technical Analysis Perspective, Is NVZMY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.